Phreesia EBITDA Margin 2019-2025 | PHR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Phreesia (PHR) over the last 10 years. The current EBITDA margin for Phreesia as of January 31, 2025 is .
| Phreesia EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-01-31 | $0.42B | $-0.03B | -6.67% |
| 2024-10-31 | $0.41B | $-0.05B | -11.85% |
| 2024-07-31 | $0.39B | $-0.07B | -17.18% |
| 2024-04-30 | $0.37B | $-0.09B | -23.26% |
| 2024-01-31 | $0.36B | $-0.11B | -29.41% |
| 2023-10-31 | $0.34B | $-0.12B | -34.22% |
| 2023-07-31 | $0.32B | $-0.13B | -39.06% |
| 2023-04-30 | $0.30B | $-0.14B | -44.70% |
| 2023-01-31 | $0.28B | $-0.15B | -53.02% |
| 2022-10-31 | $0.26B | $-0.16B | -59.92% |
| 2022-07-31 | $0.25B | $-0.15B | -62.86% |
| 2022-04-30 | $0.23B | $-0.13B | -57.89% |
| 2022-01-31 | $0.21B | $-0.09B | -43.66% |
| 2021-10-31 | $0.20B | $-0.06B | -28.93% |
| 2021-07-31 | $0.18B | $-0.03B | -16.20% |
| 2021-04-30 | $0.16B | $-0.01B | -7.36% |
| 2021-01-31 | $0.15B | $-0.01B | -5.41% |
| 2020-10-31 | $0.14B | $0.00B | -2.88% |
| 2020-07-31 | $0.13B | 0 | 0.00% |
| 2020-04-30 | $0.13B | $0.00B | 0.77% |
| 2020-01-31 | $0.13B | $0.00B | 1.60% |
| 2019-07-31 | $0.08B | $0.00B | 1.19% |
| 2019-04-30 | $0.08B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.537B | $0.420B |
| Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $39.096B | 54.00 |
| Hims & Hers Health (HIMS) | United States | $13.681B | 142.14 |
| Tempus AI (TEM) | United States | $11.156B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.596B | 71.81 |
| IRhythm Technologies (IRTC) | United States | $4.484B | 0.00 |
| Privia Health (PRVA) | United States | $2.963B | 202.50 |
| Enovis (ENOV) | United States | $2.069B | 11.53 |
| Schrodinger (SDGR) | United States | $1.747B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.691B | 0.00 |
| Omnicell (OMCL) | United States | $1.346B | 23.74 |
| Azenta (AZTA) | United States | $1.233B | 57.32 |
| 10x Genomics (TXG) | United States | $1.115B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.517B | 154.50 |
| Veradigm (MDRX) | United States | $0.455B | 0.00 |
| Claritev (CTEV) | United States | $0.435B | 0.00 |
| Standard BioTools (LAB) | United States | $0.406B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 825.00 |
| Health Catalyst (HCAT) | United States | $0.291B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.205B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| CareCloud (CCLD) | United States | $0.086B | 3.27 |
| MDxHealth SA (MDXH) | Belgium | $0.084B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.083B | 0.00 |
| Outset Medical (OM) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.059B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |